002773 康弘药业
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额1,408,2761,411,8751,218,411925,153494,114
投资活动产生之现金流量净额(2,732,633)(112,056)6,616(215,553)(803,136)
筹资活动产生之现金流量净额(519,112)(344,139)(130,498)(73,851)(78,839)
汇率变动对现金及现金等价物的影响(552)(246)(212)987(869)
现金及现金等价物净增加/(减少)(1,844,021)955,4331,094,318636,736(388,730)
期初现金及现金等价物余额5,625,4274,669,9943,575,6762,938,9403,327,670
期末现金及现金等价物余额3,781,4065,625,4274,669,9943,575,6762,938,940